Home>R&D>R&D Team

R&D Team

Our R&D Center is recognized as a national level enterprise technical center and a post-doctoral workstation.
As we continue to grow, R&D professionals of high caliber join our team.
Our R&D Center has a cluster of tip-top scientists and R&D personnel from China and America.
At present, we have 887 drug R&D personnel, of which 535 of them have senior titles or above and 105 of them have doctoral degrees, enabling us to have a strong talent base.

Shao Ying

Vice president, director of research and development center

Fu Jiemin

President Senior Advisor, National New Drug Review Expert

Deng Jie

One of high-value generic drug team leaders

Wang Weibo

One of small-molecule chemical drug innovation team leaders, a talent introduced based on “1000-tablent Plan” of the Organization Department of the Central Committee of the CPC.

Liu Shigao

One of macro molecule biological similimum research and development team leaders, made full participation in the development of Orencia (rheumatoid arthritis drug) and Vectibix (colon cancer drug)

Liu Xuejun

Deputy Director of the research and development center, and one of leaders high-value generic drug and special formulation technology research and development team

Lie Huangshu

One of high-value generic drug team leaders

Zhao Xingyu

One of small-molecule chemical drug innovation team leaders

Jiang Weidong

One of macro molecule biological similimum research and development team leaders, ever led and participated in the research and development of Vitaxin, Rituxan Bio better and other several antibodies and protein drugs